Income tax expense · 2011–2025
Emergent Biosolutions income tax expense
$30.2M−36.7% · FY2025
Emergent Biosolutions (EBS) reported $30.2M in income tax expense for fiscal 2025, −36.7% year on year.
| Fiscal year | Income tax expense | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $30.2M | −36.7% | Open → |
| FY20242024-12-31 | $47.7M | +62.8% | Open → |
| FY20232023-12-31 | $29.3M | +$36.7M | Open → |
| FY20222022-12-31 | −$7.4M | −$91.1M | Open → |
| FY20212021-12-31 | $83.7M | −21.1% | Open → |
| FY20202020-12-31 | $106M | +363.3% | Open → |
| FY20192019-12-31 | $22.9M | +21.8% | Open → |
| FY20182018-12-31 | $18.8M | −47.8% | Open → |
| FY20172017-12-31 | $36.0M | −1.9% | Open → |
| FY20162016-12-31 | $36.7M | −17.2% | Open → |
| FY20152015-12-31 | $44.3M | +48.0% | Open → |
| FY20142014-12-31 | $29.9M | +128.3% | Open → |
| FY20132013-12-31 | $13.1M | −5.8% | Open → |
| FY20122012-12-31 | $13.9M | −12.1% | Open → |
| FY20112011-12-31 | $15.8M | — | Open → |
Income tax expense — Income tax expense is the tax a company charged against profit in its income statement for the year. It is not the same as the cash it handed to tax authorities: deferred tax, provisions and timing differences separate the two, often by billions. The cash figure is a different line in the cash-flow statement.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +4.7%
Income tax expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Emergent Biosolutions income tax expense |url=https://companiesranked.com/en/company/emergent-biosolutions/income-tax-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Emergent Biosolutions income tax expense. CompaniesRanked. https://companiesranked.com/en/company/emergent-biosolutions/income-tax-expenseBibTeX
@misc{companiesranked-en-company-emergent-biosolutions-income-tax-expense-2026,
author = {{CompaniesRanked}},
title = {{Emergent Biosolutions income tax expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/emergent-biosolutions/income-tax-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001367644-26-000015 · February 27, 2026
{{cite web |title=Emergent Biosolutions income tax expense — 10-K (0001367644-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1367644/000136764426000015/ebs-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.